US Patent 11096988 CD80 variant immunomodulatory proteins and uses thereof
Patent 11096988 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on August, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 28, 2021
0
Date of Patent
August 24, 2021
0
Patent Applicant
Patent Application Number
20210128
0
Patent Citations Received
Patent Inventor Names
Joseph L. Kuijper
0
Mark F. Maurer
0
Michael Kornacker
0
Ryan Swanson
0
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11096988 CD80 variant immunomodulatory proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.